Videos

Quantitative Fluorescent Western Blotting for Protein Analysis in Neurodegenerative Diseases
23 July 2014

Dr Tom Wishart from The Roslin Institute, University of Edinburgh, describes the factors involved in neurodegenerative diseases. At the protein level, quantitative fluorescent western blotting is used to analyze neurodegenerative progression as it requires reduced sample concentrations, which can be crucial when working with precious and limited samples such as human patient samples or those from sub-cellular fractionation. Additionally, membranes can be frozen and archived at -80ºC for later re-probing allowing the generation of a membrane based bio-bank for future experimental analyses.

Tags: neuroscience, fluorescence, alzheimers disease, huntingtons disease, blotting

LI-COR Biosciences Visit website

Products in this video

For the latest articles visit the articles pages

SORT BY

6 of 93 Page ... 4 5 6 ... Next

Nutrition, Hydration & Athletic Performance	Player Psychology: Managing the World's Elite	The Problem with Food Allergens: Substitutions in ...	Avanti JXN High Performance Centrifuge	Infrared Fluorescence and Chemiluminescence for We...
Advances in Laboratory Diagnostics Podcast 4 – Bio...	Biosen Glucose and Lactate Analyzer	The Future of Mass Spectrometry in Food Science	Speciation Detection using Next Generation Sequenc...	Alcohol Testing and Air Pollution Monitoring in Br...
Welcome to the FIFA World Cup Special Feature	Step Inside the Brazilian Army's Mobile Testing La...	The Truth Behind FIFA’s Anti-Doping Policy	Advances in High-Res MS for Detecting Emerging Haz...	Food Safety Risk Assessment using LED Spectral Ima...
Horiba Scientific XploRA One: Streamline Your Rama...	The Power of Molecular Genotyping for Sickle Cell ...	NanoCHIP XL for Molecular Diagnostics	Cellular Solution of All Shapes and Sizes	Automation of the NEBNext Ultra Directional RNA Li...